Citadel Advisors’s Rockwell Medical RMTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.5K | Sell |
1,960
-2,420
| -55% | -$24.1K | ﹤0.01% | 12695 |
|
|
2025
Q4 | $36.5K | Buy |
+4,380
| New | +$44.2K | ﹤0.01% | 12152 |
|
|
2025
Q3 | – | Sell |
-12,850
| Closed | -$109K | – | 13887 |
|
|
2025
Q2 | $109K | Buy |
12,850
+3,570
| +38% | +$36.4K | ﹤0.01% | 11263 |
|
|
2025
Q1 | $105K | Buy |
9,280
+2,250
| +32% | +$40.8K | ﹤0.01% | 11386 |
|
|
2024
Q4 | $143K | Buy |
7,030
+2,800
| +66% | +$81.7K | ﹤0.01% | 10960 |
|
|
2024
Q3 | $168K | Buy |
4,230
+3,130
| +285% | +$84.2K | ﹤0.01% | 10408 |
|
|
2024
Q2 | $19.4K | Buy |
1,100
+180
| +20% | +$3.05K | ﹤0.01% | 12677 |
|
|
2024
Q1 | $15.3K | Sell |
920
-40
| -4% | -$582 | ﹤0.01% | 13197 |
|
|
2023
Q4 | $18.1K | Buy |
960
+150
| +19% | +$2.82K | ﹤0.01% | 12701 |
|
|
2023
Q3 | $16.8K | Sell |
810
-960
| -54% | -$29.2K | ﹤0.01% | 12757 |
|
|
2023
Q2 | $96.6K | Buy |
1,770
+1,600
| +941% | +$49.2K | ﹤0.01% | 10995 |
|
|
2023
Q1 | $3.08K | Buy |
170
+20
| +13% | +$345 | ﹤0.01% | 14073 |
|
|
2022
Q4 | $1.52K | Buy |
+150
| New | +$1.6K | ﹤0.01% | 14461 |
|
|
2022
Q2 | – | Sell |
-301
| Closed | -$16K | – | 13921 |
|
|
2022
Q1 | $16K | Buy |
301
+153
| +103% | +$6.48K | ﹤0.01% | 13298 |
|
|
2021
Q4 | $7K | Buy |
+148
| New | +$7.93K | ﹤0.01% | 13681 |
|
|
2021
Q3 | – | Sell |
-380
| Closed | -$38K | – | 14523 |
|
|
2021
Q2 | $38K | Sell |
380
-290
| -43% | -$29.9K | ﹤0.01% | 13429 |
|
|
2021
Q1 | $85K | Buy |
670
+365
| +120% | +$54K | ﹤0.01% | 12601 |
|
|
2020
Q4 | $34K | Buy |
305
+117
| +62% | +$13.1K | ﹤0.01% | 10689 |
|
|
2020
Q3 | $22K | Buy |
188
+94
| +100% | +$16.3K | ﹤0.01% | 9838 |
|
|
2020
Q2 | $20K | Sell |
94
-234
| -71% | -$55.3K | ﹤0.01% | 9551 |
|
|
2020
Q1 | $74K | Buy |
+328
| New | +$93.5K | ﹤0.01% | 8830 |
|
|
2019
Q3 | – | Sell |
-230
| Closed | -$76K | – | 9670 |
|
|
2019
Q2 | $76K | Sell |
230
-195
| -46% | -$99K | ﹤0.01% | 8614 |
|
|
2019
Q1 | $266K | Buy |
425
+150
| +55% | +$68.4K | ﹤0.01% | 7787 |
|
|
2018
Q4 | $68K | Sell |
275
-13
| -5% | -$5.17K | ﹤0.01% | 8407 |
|
|
2018
Q3 | $134K | Buy |
+288
| New | +$139K | ﹤0.01% | 8450 |
|
|
2018
Q2 | – | Sell |
-223
| Closed | -$128K | – | 9216 |
|
|
2018
Q1 | $128K | Sell |
223
-302
| -58% | -$191K | ﹤0.01% | 7619 |
|
|
2017
Q4 | $336K | Buy |
525
+128
| +32% | +$90.2K | ﹤0.01% | 6272 |
|
|
2017
Q3 | $374K | Buy |
+397
| New | +$304K | ﹤0.01% | 5722 |
|
|
2017
Q2 | – | Sell |
-489
| Closed | -$337K | – | 7965 |
|
|
2017
Q1 | $337K | Sell |
489
-136
| -22% | -$89.6K | ﹤0.01% | 5704 |
|
|
2016
Q4 | $450K | Buy |
625
+296
| +90% | +$205K | ﹤0.01% | 5067 |
|
|
2016
Q3 | $243K | Sell |
329
-136
| -29% | -$110K | ﹤0.01% | 6019 |
|
|
2016
Q2 | $387K | Sell |
465
-412
| -47% | -$383K | ﹤0.01% | 4842 |
|
|
2016
Q1 | $725K | Sell |
877
-305
| -26% | -$240K | ﹤0.01% | 3883 |
|
|
2015
Q4 | $1.33M | Buy |
1,182
+433
| +58% | +$504K | ﹤0.01% | 3238 |
|
|
2015
Q3 | $635K | Sell |
749
-84
| -10% | -$122K | ﹤0.01% | 4447 |
|
|
2015
Q2 | $1.48M | Buy |
833
+280
| +51% | +$356K | ﹤0.01% | 3431 |
|
|
2015
Q1 | $665K | Buy |
553
+95
| +21% | +$111K | ﹤0.01% | 4499 |
|
|
2014
Q4 | $518K | Buy |
458
+113
| +33% | +$116K | ﹤0.01% | 4680 |
|
|
2014
Q3 | $347K | Sell |
345
-505
| -59% | -$570K | ﹤0.01% | 5083 |
|
|
2014
Q2 | $1.12M | Sell |
850
-21
| -2% | -$25.3K | ﹤0.01% | 3355 |
|
|
2014
Q1 | $1.21M | Buy |
871
+96
| +12% | +$125K | ﹤0.01% | 3194 |
|
|
2013
Q4 | $891K | Sell |
775
-148
| -16% | -$204K | ﹤0.01% | 3326 |
|
|
2013
Q3 | $1.16M | Buy |
923
+275
| +42% | +$187K | ﹤0.01% | 2950 |
|
|
2013
Q2 | $257K | Buy |
+648
| New | +$275K | ﹤0.01% | 4439 |
|
Other funds holding RMTI
VCM
VFT
WANY
Citadel Advisors's RMTI Position: Q1 2026 in Review
Citadel Advisors sold out of Rockwell Medical (RMTI) in Q1 2026, closing a stake of 8,189 shares — an estimated $81.6K sold.
Citadel Advisors first reported a position in RMTI in Q2 2013 and held it in 41 quarters. The position peaked at $772K in Q4 2014. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.
- Citadel Advisors reported no remaining Rockwell Medical position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 8,189 Rockwell Medical shares in Q1 2026, an estimated $81.6K.
- Citadel Advisors first reported a position in Rockwell Medical in Q2 2013 and held it in 41 quarters.
- Citadel Advisors's Rockwell Medical position peaked at $772K in Q4 2014.
- 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.